Share on StockTwits

Cytosorbents Corp (NASDAQ:CTSO) Director Al Kraus sold 100,000 shares of the stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $0.28, for a total value of $28,000.00. Following the transaction, the director now directly owns 1,393,631 shares of the company’s stock, valued at approximately $390,217. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Cytosorbents Corp (NASDAQ:CTSO) traded down 8.97% during mid-day trading on Wednesday, hitting $0.264. The stock had a trading volume of 2,583,645 shares. Cytosorbents Corp has a 52 week low of $0.08 and a 52 week high of $0.35. The stock has a 50-day moving average of $0.24 and a 200-day moving average of $0.24. The company’s market cap is $78.9 million.

Cytosorbents Corp (NASDAQ:CTSO) last released its earnings data on Tuesday, August 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). Analysts expect that Cytosorbents Corp will post $-0.03 EPS for the current fiscal year.

CytoSorbents Corporation is a development stage critical care focused company using blood purification to treat life-threatening illnesses.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.